Specifically, diosgenin can significantly inhibit the growth of sarcoma-180 tumor by improving both specific and nonspecific cellular immune effects23, increase the expressions of IFN-γ and antigen-specific IgG2a, and enhance immune response mediated by Th1 cells24. Here, IFNG is linked to neoplasm.